Pacgen Life Science Corporation announced that its partner, General Biologicals Corporation has added new markets for P113 products licensed from Pacgen. Subject to regulatory approval, P113 mouth rinse and mouth sprays will be made available in Southern China in addition to their existing markets in Taiwan. GBC has signed an agreement with Dongguan Biotech Industrial Development Co. based in Guangdong Province, China to distribute its oral hygiene and hepatitis testing products. As part of the distribution deal, GBC has granted Dongguan Biotech exclusive right to distribute its products in the Guangdong Province. In exchange for the regional distribution right, GBC will receive up to CNY 4.5 million of milestone payments for the first year. Pacgen is entitled to royalties based on sales of P113 products in accordance with its licensing agreement with GBC.